Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILENT TECHNOLOGIES, INC.

(A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

RareCyte, Inc. announced that it has received $24 million in funding from Arboretum Ventures LLC, F Prime, Inc., Agilent Technologies, Inc., HealthQuest Capital, 5AM Venture Management, LLC and other investors

09/09/2021 EDT

RareCyte, Inc. announced that it has received $24,000,000 in a round of funding led by new investor, Arboretum Ventures LLC on September 9, 2021. The transaction also included participation from new investors, F Prime, Inc., Logos Capital, Agilent Technologies, Inc., existing investors, HealthQuest Capital, 5AM Venture Management, LLC and Ron Seubert. As a part of the transaction, Jan Garfinkle from Arboretum Ventures LLC and Robert Weisskoff from F Prime, Inc. has joined board of directors of the company.


ę S&P Capital IQ 2021
All news about AGILENT TECHNOLOGIES, INC.
10/21AGILENT TECHNOLOGIES : PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnost..
PU
10/21AGILENT TECHNOLOGIES : Technology Networks Limited - Agilent Science Futures, The Impact o..
AQ
10/14VC DAILY : Sprinter Health Collects $33 Million to Join Home-Healthcare Race
DJ
10/13AGILENT TECHNOLOGIES : Eli Lilly Get FDA's OK for Assay to Identify Early Breast Cancer
MT
10/13AGILENT TECHNOLOGIES : Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 phar..
BU
10/13Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-..
CI
10/12Akadeum Life Sciences, Inc. announced that it has received $17.5 million in funding fro..
CI
10/04AGILENT TECHNOLOGIES, INC. : Ex-dividend day for
FA
09/28AGILENT TECHNOLOGIES : Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vi..
BU
09/24AGILENT TECHNOLOGIES : Dr. Mikael Dolsten Named to Agilent Board of Directors, Pfizer exec..
AQ
More news
Analyst Recommendations on AGILENT TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2021 6 317 M - -
Net income 2021 1 075 M - -
Net Debt 2021 1 485 M - -
P/E ratio 2021 45,3x
Yield 2021 0,48%
Capitalization 47 821 M 47 821 M -
EV / Sales 2021 7,81x
EV / Sales 2022 7,27x
Nbr of Employees 16 700
Free-Float 99,7%
Chart AGILENT TECHNOLOGIES, INC.
Duration : Period :
Agilent Technologies, Inc. Technical Analysis Chart | A | US00846U1016 | MarketScreener
Technical analysis trends AGILENT TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 157,97 $
Average target price 172,40 $
Spread / Average Target 9,13%
EPS Revisions
Managers and Directors
Michael R. McMullen President, Chief Executive Officer & Director
Robert W. McMahon Chief Financial Officer & Senior Vice President
Koh Boon Hwee Non-Executive Chairman
Darlene J. S. Solomon Chief Technology Officer & Senior Vice President
Katharine Knobil Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
AGILENT TECHNOLOGIES, INC.33.32%47 821
THERMO FISHER SCIENTIFIC31.38%240 757
DANAHER CORPORATION41.07%223 934
INTUITIVE SURGICAL, INC.25.24%122 004
SIEMENS HEALTHINEERS AG40.64%77 031
EDWARDS LIFESCIENCES CORPORATION27.80%72 674